Federated Estimation of Population Pharmacokinetic Models with Exact Equivalence to Pooled-Data Analysis.

IF 4.1 3区 医学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Pharmaceutical Research Pub Date : 2026-09-01 Epub Date: 2026-09-17 DOI:10.1007/s11095-026-04203-3
Yuta Nakamaru, Mizuki Uno, Yiran Song, Kanako So, Tomoko Kita, Fumiyoshi Yamashita
{"title":"Federated Estimation of Population Pharmacokinetic Models with Exact Equivalence to Pooled-Data Analysis.","authors":"Yuta Nakamaru, Mizuki Uno, Yiran Song, Kanako So, Tomoko Kita, Fumiyoshi Yamashita","doi":"10.1007/s11095-026-04203-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Population pharmacokinetic (PopPK) analysis relies on nonlinear mixed-effects modeling of pooled data; however, sharing subject-level data across sites is often restricted. This study develops a federated framework that exactly recovers the global objective function corresponding to centralized pooled-data analysis, thereby yielding identical parameter estimates without sharing subject-level data.</p><p><strong>Methods: </strong>Each site computes its local contributions to the global objective function and corresponding gradients. A central server aggregates these quantities to reconstruct the global objective function and gradient at each parameter value. Performance was evaluated using simulations of a one-compartment oral model under two multi-site scenarios: heterogeneous sparse sampling and between-site heterogeneity in covariate distribution. Federated estimation was compared with centralized pooled-data estimation, independent site-specific estimation, and weighted combination of site-specific estimates and variances. Parameter uncertainty was assessed using bootstrap resampling.</p><p><strong>Results: </strong>Across scenarios, federated estimation yielded parameter estimates and bootstrap confidence intervals that closely matched with those from centralized pooled-data estimation for fixed effects, between-subject variability, and residual error. In contrast, independent site-specific estimation showed deviations under certain conditions, and weighted pooling of site-specific estimates did not reproduce centralized variance estimates.</p><p><strong>Conclusions: </strong>The proposed federated framework enables mathematically equivalent PopPK estimation without sharing subject-level data.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":"2957-2966"},"PeriodicalIF":4.1000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11095-026-04203-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Population pharmacokinetic (PopPK) analysis relies on nonlinear mixed-effects modeling of pooled data; however, sharing subject-level data across sites is often restricted. This study develops a federated framework that exactly recovers the global objective function corresponding to centralized pooled-data analysis, thereby yielding identical parameter estimates without sharing subject-level data.

Methods: Each site computes its local contributions to the global objective function and corresponding gradients. A central server aggregates these quantities to reconstruct the global objective function and gradient at each parameter value. Performance was evaluated using simulations of a one-compartment oral model under two multi-site scenarios: heterogeneous sparse sampling and between-site heterogeneity in covariate distribution. Federated estimation was compared with centralized pooled-data estimation, independent site-specific estimation, and weighted combination of site-specific estimates and variances. Parameter uncertainty was assessed using bootstrap resampling.

Results: Across scenarios, federated estimation yielded parameter estimates and bootstrap confidence intervals that closely matched with those from centralized pooled-data estimation for fixed effects, between-subject variability, and residual error. In contrast, independent site-specific estimation showed deviations under certain conditions, and weighted pooling of site-specific estimates did not reproduce centralized variance estimates.

Conclusions: The proposed federated framework enables mathematically equivalent PopPK estimation without sharing subject-level data.

群体药代动力学模型与混合数据分析完全等价的联合估计。
目的:群体药代动力学(PopPK)分析依赖于混合数据的非线性混合效应建模;但是,跨站点共享主题级数据通常受到限制。本研究开发了一个联邦框架,该框架精确地恢复了与集中池数据分析相对应的全局目标函数,从而在不共享主题级数据的情况下产生相同的参数估计。方法:每个站点计算其对全局目标函数的局部贡献和相应的梯度。中央服务器将这些数量聚合在一起,在每个参数值处重建全局目标函数和梯度。通过模拟单室口腔模型在两种多站点情况下的表现进行评估:异质性稀疏采样和协变量分布的站点间异质性。将联邦估计与集中的池数据估计、独立的特定地点估计以及特定地点估计和方差的加权组合进行比较。采用自举重采样评估参数不确定性。结果:在各种情况下,联合估计产生的参数估计和自举置信区间与集中的池数据估计的固定效应、受试者之间的可变性和剩余误差密切匹配。相比之下,独立的特定地点估计在某些条件下会出现偏差,特定地点估计的加权池不能再现集中的方差估计。结论:提出的联邦框架可以在不共享主题级数据的情况下实现数学上等效的PopPK估计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutical Research
Pharmaceutical Research 医学-化学综合
CiteScore
6.60
自引率
5.40%
发文量
276
审稿时长
3.4 months
期刊介绍: Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to: -(pre)formulation engineering and processing- computational biopharmaceutics- drug delivery and targeting- molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)- pharmacokinetics, pharmacodynamics and pharmacogenetics. Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书